- Home
- SYRA vs HOTH Comparison
SYRA vs HOTH Comparison
Compare SYRA & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRA
- HOTH
- Stock Information
- Founded
- SYRA 2020
- HOTH 2017
- Country
- SYRA United States
- HOTH United States
- Employees
- SYRA N/A
- HOTH N/A
- Industry
- SYRA Other Specialty Stores
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- SYRA Industrials
- HOTH Health Care
- Exchange
- SYRA Nasdaq
- HOTH Nasdaq
- Market Cap
- SYRA 4.9M
- HOTH 4.9M
- IPO Year
- SYRA 2023
- HOTH 2019
- Fundamental
- Price
- SYRA $0.43
- HOTH $1.24
- Analyst Decision
- SYRA
- HOTH Strong Buy
- Analyst Count
- SYRA 0
- HOTH 4
- Target Price
- SYRA N/A
- HOTH $4.75
- AVG Volume (30 Days)
- SYRA 4.9M
- HOTH 25.7M
- Earning Date
- SYRA 03-24-2025
- HOTH 03-27-2025
- Dividend Yield
- SYRA N/A
- HOTH N/A
- EPS Growth
- SYRA N/A
- HOTH N/A
- EPS
- SYRA N/A
- HOTH N/A
- Revenue
- SYRA $7,741,558.00
- HOTH N/A
- Revenue This Year
- SYRA $47.74
- HOTH N/A
- Revenue Next Year
- SYRA N/A
- HOTH N/A
- P/E Ratio
- SYRA N/A
- HOTH N/A
- Revenue Growth
- SYRA 35.47
- HOTH N/A
- 52 Week Low
- SYRA $0.34
- HOTH $0.58
- 52 Week High
- SYRA $8.37
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- SYRA 45.09
- HOTH 48.43
- Support Level
- SYRA $0.37
- HOTH $1.16
- Resistance Level
- SYRA $0.55
- HOTH $1.35
- Average True Range (ATR)
- SYRA 0.06
- HOTH 0.15
- MACD
- SYRA -0.01
- HOTH -0.05
- Stochastic Oscillator
- SYRA 23.91
- HOTH 10.91
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.